JPH10338636A5 - - Google Patents
Info
- Publication number
- JPH10338636A5 JPH10338636A5 JP1997163543A JP16354397A JPH10338636A5 JP H10338636 A5 JPH10338636 A5 JP H10338636A5 JP 1997163543 A JP1997163543 A JP 1997163543A JP 16354397 A JP16354397 A JP 16354397A JP H10338636 A5 JPH10338636 A5 JP H10338636A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- general formula
- r4co
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16354397A JP4176170B2 (ja) | 1997-06-06 | 1997-06-06 | アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16354397A JP4176170B2 (ja) | 1997-06-06 | 1997-06-06 | アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH10338636A JPH10338636A (ja) | 1998-12-22 |
| JPH10338636A5 true JPH10338636A5 (cg-RX-API-DMAC10.html) | 2005-03-17 |
| JP4176170B2 JP4176170B2 (ja) | 2008-11-05 |
Family
ID=15775896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16354397A Expired - Fee Related JP4176170B2 (ja) | 1997-06-06 | 1997-06-06 | アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4176170B2 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3692492B2 (ja) * | 2001-05-01 | 2005-09-07 | 独立行政法人科学技術振興機構 | 新規なスフィンゴ脂質合成阻害剤 |
| US6855830B2 (en) | 2001-07-16 | 2005-02-15 | Genzyme Corporation | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| BRPI0517701A8 (pt) | 2004-11-10 | 2018-01-23 | Genzyme Corp | métodos de tratamento de diabetes mellitus |
| ES2546181T3 (es) | 2006-05-09 | 2015-09-21 | Genzyme Corporation | Métodos de tratar la enfermedad del hígado graso mediante inhibición de la síntesis de glucoesfingolípidos |
| EP2594565B1 (en) | 2007-05-31 | 2018-10-24 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| KR101640263B1 (ko) | 2007-10-05 | 2016-07-15 | 젠자임 코포레이션 | 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법 |
| JP2011529500A (ja) | 2008-07-28 | 2011-12-08 | ジェンザイム コーポレーション | 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害 |
| CN102271678B (zh) | 2008-10-03 | 2017-06-30 | 简詹姆公司 | 2‑酰胺基丙醇型葡糖神经酰胺合成酶抑制剂 |
| MY192644A (en) | 2009-11-27 | 2022-08-29 | Genzyme Corp | An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase |
| CN110372636B (zh) | 2013-09-20 | 2023-03-28 | 生物马林药物股份有限公司 | 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂 |
-
1997
- 1997-06-06 JP JP16354397A patent/JP4176170B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2579323B2 (ja) | ジアミン類の選択的アミジン化 | |
| EP2085391A3 (en) | Inhibitors of factor XA and other serine proteases involved in the coagulation cascade | |
| AU5249898A (en) | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | |
| NZ336379A (en) | Nitric oxide synthase inhibitor, use and process of preparation | |
| FR2575753B1 (fr) | Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP2201945A3 (en) | Use of substituted 2-aminoacetamides for treating or ameliorating anxiety | |
| KR950703349A (ko) | N-치환 올리고머의 합성(synthesis of n-substituted oligomers) | |
| CA2347752A1 (en) | N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them | |
| JP2002503673A5 (cg-RX-API-DMAC10.html) | ||
| SG167655A1 (en) | Method for the preparation of pure citalopram | |
| ATE46696T1 (de) | 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung. | |
| KR930019690A (ko) | 베타-아미노산의 신규 유도체 | |
| JP2004505097A5 (cg-RX-API-DMAC10.html) | ||
| CN1087349C (zh) | N-乙酰基-(L)-4-氰基苯丙氨酸Ac-(L)-Phe(4-CN)-OH与N-乙酰基-(L)-对脒基苯丙氨酸-环己基甘氨酸-β-(3-N-甲基吡啶鎓)-丙氨酸AC-(L)-PAPh-chg-PaIMe(3)-NH2的新颖的制备方法 | |
| PL346554A1 (en) | Method of synthesising n-[(s)-1-carboxybutyl]-(s)-alanine esters | |
| WO1995017439A3 (en) | Process for preparing carbamates | |
| DE69429753D1 (de) | Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung | |
| KR950032097A (ko) | 15-데옥시스페르구아린 유사체, 이들의 제조방법 및 치료학적인 용도 | |
| EA200001107A1 (ru) | ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ | |
| IN189969B (cg-RX-API-DMAC10.html) | ||
| KR890009974A (ko) | 신규 화합물들 | |
| JP2853020B2 (ja) | グアニジン誘導体及びその製造方法 | |
| JP2000026383A (ja) | テアニンの製造方法 | |
| JPS6354322A (ja) | 副作用の軽減されたペネム型またはカルバペネム型抗生物質製剤 | |
| KR960004334A (ko) | 신규한 아세틸살리실산 유도체 및 그의 제조방법 |